-
digital.ahrq.gov/sites/default/files/docs/publication/2014-jason-data-for-individual-health.pdf
January 01, 2014 - Any device falling short of this end-to-end requirement
lacks a fully scientific basis as reproducibility … PIECES system is:
“55 year old male Caucasian with a history of diabetes mel
litus and chronic renal … All that is required
is a web server front end and a database back-end to translate from the
proprietary
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rm4E5SooP2GnqJ_HVRA5M4
January 01, 2017 - All
individual studies reported end-point AHI values of 10 or less for
CPAP-treated groups, and most … end-point ESS score for the 23 trials
was <8). … b Two-stage process using MVAP for everyone and then home testing to
determine AHI for those with an … surgery of the soft palate in the
treatment of mild obstructive sleep apnea is not
effective as a single-stage … Renal sympathetic denervation in
patients with treatment-resistant hypertension
(the Symplicity HTN-2
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/carotid-artery-stenosis-screening-july-2014
July 08, 2014 - A high comorbid condition level was defined as any end-stage disease, severe disability, or 3 or more … nonfatal MI, permanent cranial nerve damage, pulmonary embolism, pneumonia, wound infection, acute renal
-
effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
March 29, 2012 - due to concerns regarding
drug-drug interactions or metabolic problems.8
For example, patients with end-stage … renal
disease are less likely to receive medications
for secondary prevention after myocardial
infarction
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/mindfulness-transcript.doc
June 10, 2014 - And we know that in the vast majority of cases, it’s the antibiotic exposure that sets the stage for … routinely meeting with our hospitalists to talk about anticoagulation dosing, dosing of antibiotics in renal … At the end of today’s call if you could all take a moment to fill out an evaluation of today’s webinar
-
www.ahrq.gov/sites/default/files/2024-09/hanchate-report.pdf
January 01, 2024 - included
(thereby excluding a small number of CABGs performed on younger patients with
disability or End-Stage … Renal Disease).
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-multifactorial-dyslipidemia/lipid-disorders-in-children-screening-july-2016
August 09, 2016 - Familial hypercholesterolemia and other monogenic conditions were excluded from this review, as were renal … Sexual maturation was evaluated at every visit through year 5 or until the participant reached Tanner stage … At the end of the study, 283 participants (3.1%) had died.
-
integrationacademy.ahrq.gov/sites/default/files/2021-04/Table_of_Opioid_and_Pain_Management_Tools_and_Resources.pdf
January 01, 2021 - Stewardship and
Safety in the ESRD
Population
Conference
presentation discusses
opioids in the end-stage … renal disease (ESRD).
-
digital.ahrq.gov/sites/default/files/docs/page/CongressionalBudgetOffice.pdf
January 01, 2009 - ate cost savings for the federal government because of the
costs of the subsidies: Payments would end … providers, insurers, and patients, is
especially difficult because health IT networks are in an
early stage … At this stage, empirical research has shown that
the use of health IT in general and CDS features in … monary disease, heart disease, diabetes, coronary artery
disease, chronic heart failure, chronic renal … “Effects of Multi-
disciplinary Case Management in Patients with
Chronic Renal Insufficiency.”
-
www.ahrq.gov/hai/cauti-tools/archived-webinars/mindfulness-transcript.html
December 01, 2017 - And we know that in the vast majority of cases, it's the antibiotic exposure that sets the stage for … routinely meeting with our hospitalists to talk about anticoagulation dosing, dosing of antibiotics in renal … At the end of today's call if you could all take a moment to fill out an evaluation of today's webinar
-
effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
January 01, 2012 - scores (IKDC form, EQ VAS
quality of life score) were reported between the baseline evaluation, the end … Barr virus-associated posttransplant lymphoproliferative disorder was
observed in patients who had renal
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/prevention-of-opioid-user-disorder-ehc-tech-brief.pdf
May 14, 2021 - identifying evidence, the EPC consulted a panel of Key
Informants who represent subject experts and end-users … Therefore, in the end, the study questions, design,
methodological approaches, and conclusions do not … Because of their
role as end users, individuals with potential conflicts may be retained. … The Helping to End Addiction Long-Term Initiative.
https://heal.nih.gov/. … Analgesic administration for patients with renal colic in
the emergency department before and after
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ongoing-studies-evidence_research.pdf
December 01, 2010 - to suggest factors that might predict relevance and utility of
the completed study and associated end-products … when compared to the trial registration, and only 45 percent of studies were registered
before the end … While many of
these registries are no longer in existence, they likely set the stage for current clinical … Additionally, the time frame
20
examined in this project is at an early stage when trial registration … Type II Diabetes and the Metabolic Syndrome and on
Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
August 23, 2022 - Asselbergs FW, Diercks GF, Hillege HL, et al; Prevention of Renal and Vascular Endstage Disease Intervention … Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type … : 26 a Daily aspirin use: 17
ALLHAT-LLT Furberg et al, 2002 18 (Fair)
Aged ≥55 y with stage … Evaluation of Rosuvastatin; MI, myocardial infarction; NR, not reported; PREVEND-IT, Prevention of Renal
-
www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Sampling-Weighting-Synthetization-Methodologies.pdf
December 01, 2023 - For Medicare, the coverage qualification reasons
were “End-stage renal disease (ESRD),” “Disability … Discharge Status
The discharge status describes the status of the person as of the service end date
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
July 01, 2023 - oral or
dental examination performed on an inpatient basis as part of comprehensive workup prior to
renal … the body’s immune system, leading to impairment of resistance to infections
and other disorders.7 Renal … reviewer was unsure
regarding the appropriate disposition of a study (either at the abstract or full-text stage … Response, a thorough search of the MEDLINE database compiled all
relevant published studies through the end … Evidence-based Practice Center (EPC) Program using
streamlined literature review methods to assist end-users
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
March 01, 2011 - The summary of final key points and
recommendations are presented in Table 2 at the end of this chapter … The two end points of IQR and range are
not symmetric around median (or mean) if the distribution of … Allowing
for uncertainty due to missing data in meta-
analysis--part 1: two-stage methods. … alter
the conclusions of a meta-analysis with
continuous outcomes: a case study of
changes in renal … monotherapy and
combination therapy with inhibitors of the
renin angiotensin system on proteinuria in
renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
January 01, 2023 - other than non-melanoma skin cancer),
HIV infection, organ transplant, liver failure or hepatic coma, end-stage … renal disease, respiratory
failure, or severe congestive heart failure. … included to reduce the potential for misclassification and referred
to the first 30 days after the end … The former use category began after indeterminate use ended (i.e., at 31 days after end of
current use … of insurance
coverage/pharmacy benefit, day before 65th birthday, or end of study period (December
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
November 01, 2008 - outcomes
data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still
in an early stage … Adverse Effects
of Cyclooxygenase 2 Inhibitors on Renal
and Arrhythmia Events: Meta-analysis of
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
November 01, 2008 - outcomes
data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still
in an early stage … Adverse Effects
of Cyclooxygenase 2 Inhibitors on Renal
and Arrhythmia Events: Meta-analysis of